MFine, the digital health startup, has raised $48 million Series C funding round co-led by Moore Strategic Ventures and BEENEXT. There was participation from existing investors, Stellaris Venture Partners, SBI Group Japan, SBI Ven Capital Singapore, Heritas Capital, Prime Venture Partners, Y’S Investment Pte Ltd. and Alteria Capital.
MFine aims to build one of the Largest Virtual Hospitals in the world and make high-quality healthcare more accessible and effective with the use of AI and mobile technologies. Towards that vision, MFine is enabling clinical decision support for doctors using AI and bringing vitals monitoring and health management to consumers’ smartphones.
“In the healthcare sector the world has changed to a new normal and we are seeing a steep growth in the adoption of digital health in India too,” said Prasad Kompalli, CEO and cofounder, MFine. “We will continue to invest in deep tech to transform every smartphone into a health companion for consumers and a decision support assistant to all doctors. We will also be looking to expand our network across India and make our services available widely.”
Since its inception, over 3 million users have used MFine services with the platform clocking over 300,000 monthly transactions that include doctor consultations, diagnostic tests, e-pharmacy and in-patient procedures. In October 2018, MFine added another layer to its virtual doctor consultations by integrating with laboratory and diagnostic services and currently provides its users access to more than 700 diagnostic centres across 400 cities in India. Over 100,000 users use MFine for booking diagnostic tests every month. More than 6000 doctors, including some of India’s top doctors from over 700 reputed hospitals practice across 35 specialties on MFine and serve millions in more than 1000 towns across India.
MFine is growing 15 per cent month on month, amidst exponential adoption of telemedicine and digital health in India since the onset of the Covid-19 pandemic and increase in the adoption of digital health among Indians. The firm is investing heavily in technology to make the telemedicine experience significantly easier and effective for quality care delivery. In early 2021, MFine launched an app-based SPO2 (blood oxygen saturation) monitoring tool which enables users to keep track of their oxygen saturation levels without needing an additional device. Since then, 250,000 users have used the tool and thousands of people continue to use it daily. In the coming months, MFine will be extending the tool to measure heart rate and blood pressure too.
The Covid-19 outbreak also pushed employers to invest into employee health benefits and many corporations are now offering various solutions that go beyond hospitalization benefits in partnership with MFine. Organizations in India are now fast turning to telemedicine as part of their employee health programs. The MFine Corporate subscription product has seen strong growth in the last year. Many corporates are offering multiple benefits programs as part of which employees and their families get access to online doctor consultations, preventive health checks, mental health consultations and chronic condition management. Over 500 corporates have partnered with MFine to enable wide-ranging services covering over 500,000 employees. In the coming months, the company will also bring innovative financial solutions for users together with insurance partners.
“The high uptake and engagement on MFine’s platform speak volumes about the pressing need for such a service not only in India but also globally,” said Hero Choudhary, managing partner, BEENEXT.
The $120 billion Health Delivery market in India is fast moving towards digitization. This is similar to other sectors like payments, banking and education, technology players are building digital-first services and vying for a significant share of the market. Government initiatives such as the announcement of Telemedicine Practice Guidelines, National Digital Health Mission (NDHM), and e-access to healthcare have further cemented an inevitable growth of the sector.
Source: business-standard.com
